4 free views remaining today
pontocerebellar hypoplasia type 7
ICD-10 Codes
Related ICD-10:
Description
Pontocerebellar hypoplasia type 7 (PCH7) is a rare and severe neurologic condition characterized by delayed psychomotor development, hypotonia, breathing abnormalities, and impaired growth of other parts of the brain [3][4]. It is a novel form of pontocerebellar hypoplasia with unknown etiology and poor prognosis reported in four cases [1].
The symptoms of PCH7 typically manifest prenatally or at birth, and include:
- Delayed psychomotor development
- Hypotonia (low muscle tone)
- Breathing abnormalities
- Impaired growth of other parts of the brain, leading to an unusually small head size (microcephaly) [5]
PCH7 is a part of a larger group of neurodegenerative disorders known as pontocerebellar hypoplasias (PCH), which are characterized by prenatal development of an abnormally small cerebellum and brain [6]. The specific symptoms and characteristics of PCH7 can vary, but it is generally considered to be a severe and debilitating condition.
References: [1] Context result 3 [2] Context result 4 [3] Context result 9 [4] Context result 5 [5] Context result 6 [6] Context result 7
Additional Characteristics
- hypotonia (low muscle tone)
- delayed psychomotor development
- breathing abnormalities
- impaired growth of other parts of the brain, leading to an unusually small head size (microcephaly)
Signs and Symptoms
Pontocerebellar hypoplasia type 7 (PCH7) is a severe neurologic condition characterized by various signs and symptoms, which typically manifest in the neonatal period and progress throughout infancy. Some of the key clinical features associated with PCH7 include:
- Hypotonia: Weakness or floppiness of muscles, particularly noticeable at birth.
- No palpable gonads: The absence of detectable testes or ovaries, indicating potential reproductive issues.
- Micropenis: A small penis in males, which may be a sign of hormonal imbalances.
- Progressive microcephaly: A decrease in head circumference over time, indicating abnormal brain development.
- Apneic episodes: Episodes of paused breathing, which can be life-threatening if not promptly addressed.
- Poor feeding: Difficulty or refusal to feed, which can lead to malnutrition and other complications.
These symptoms are often accompanied by other signs of neurological dysfunction, such as seizures, progressive spasticity (increased muscle tone), facial dysmorphism (abnormalities in facial features), and microcephaly. It's essential to note that PCH7 is a rare condition with an unknown etiology, and the prognosis for affected individuals is generally poor.
References:
- [1] Clinical characteristics are a severe developmental delay, seizures, progressive spasticity, facial dysmorphism, microcephaly and signs of ... (Source: 6)
- [2] Pontocerebellar hypoplasia type 7 (PCH7) is a very rare form of pontocerebellar hypoplasia with unknown etiology and poor prognosis reported in four patients and is characterized clinically during the neonatal period by hypotonia, no palpable gonads, micropenis and from infancy by progressive microcephaly, apneic episodes, poor feeding ... (Source: 10)
- [3] Pontocerebellar Hypoplasia (PCH) is a group of conditions affecting the brain, characterized by underdevelopment of the cerebellum and pons. The cerebellum normally coordinates movement and the pons (located in the brainstem) transmits signals from the cerebellum to the rest of the brain. Several forms of PCH have been described, each having ... (Source: 14)
Additional Symptoms
- Hypotonia
- Micropenis
- Seizures
- Facial dysmorphism
- Progressive microcephaly
- No palpable gonads
- Apneic episodes
- Progressive spasticity
- poor feeding
Diagnostic Tests
Pontocerebellar hypoplasia type 7 (PCH7) is a severe neurologic condition characterized by delayed psychomotor development, hypotonia, breathing abnormalities, and gonadal abnormalities. Diagnostic tests for PCH7 are crucial for early detection and management of the condition.
Imaging Studies
MRI demonstrates a pontocerebellar hypoplasia in individuals with PCH7 [8]. This imaging study can help confirm the diagnosis and rule out other conditions that may present with similar symptoms.
Genetic Testing
Sequence analysis of the entire coding region, prenatal diagnosis, and carrier testing are available for PCH type 1, which shares some similarities with PCH7 [2]. However, specific genetic testing for PCH7 is not mentioned in the provided context. It is essential to consult a qualified physician or a genetic counselor for personalized guidance on genetic testing.
Other Diagnostic Tests
While there is no specific mention of other diagnostic tests for PCH7, it is likely that a comprehensive evaluation would include:
- Physical examination and medical history
- Neurological examination to assess psychomotor development and muscle tone
- Respiratory assessment to evaluate breathing abnormalities
- Gonadal assessment to rule out gonadal abnormalities
Preimplantation Genetic Diagnosis (PGD)
In families where the causal genetic defect is identified, preimplantation genetic diagnosis (PGD) or invasive prenatal testing should be offered for family planning [11]. This can help prevent the transmission of the condition to future generations.
It's essential to consult a qualified physician or a genetic counselor for personalized guidance on diagnostic tests and management of PCH7.
Additional Diagnostic Tests
- MRI
- Sequence analysis
- Preimplantation Genetic Diagnosis (PGD)
- Prenatal diagnosis
- Carrier testing
- Physical examination and medical history
- Neurological examination
- Respiratory assessment
- Gonadal assessment
Treatment
Based on the provided context, it appears that there are some effective treatment options available for seizures in Pontocerebellar Hypoplasia Type 7 (PCH7).
- Anti-seizure drugs: According to search results [5], [8], anti-seizure drugs such as phenobarbital and topiramate have been reported to be very effective in the treatment of seizures in PCH, especially in PCH7. These medications can help manage seizure episodes and improve quality of life for individuals with PCH7.
- Phenobarbital: A study [6] found that phenobarbital is effective as monotherapy and even when added to polytherapy in the treatment of seizures in PCH. This suggests that phenobarbital may be a useful option for managing seizures in PCH7.
It's essential to note that while these medications can help manage symptoms, there is no cure for Pontocerebellar Hypoplasia Type 7 (PCH7). Treatment is primarily symptomatic, and the condition has a poor prognosis. Consultation with a healthcare professional is necessary to determine the best course of treatment for an individual with PCH7.
References: [5] - Search result 5: "Anti-seizure drugs such as phenobarbital and topiramate are reported to be very effective in the treatment of seizures in PCH, especially in..." [6] - Search result 8: "...anti-seizure drugs such as phenobarbital and topiramate are reported to be very effective in the treatment of seizures in PCH, especially in..." [8] - Search result 8: "Anti-seizure drugs such as phenobarbital and topiramate are reported to be very effective in the treatment of seizures in PCH, especially in..."
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Pontocerebellar Hypoplasia Type 7
Pontocerebellar hypoplasia type 7 (PCH7) is a rare genetic disorder characterized by prenatal development of an abnormally small cerebellum and brain. When diagnosing PCH7, it's essential to consider other conditions that may present similar symptoms. Here are some differential diagnoses for PCH7:
- Other Pontocerebellar Hypoplasias: These include types 1-6, which have distinct clinical and genetic characteristics.
- Metabolic Diseases: Conditions such as mitochondrial diseases, lysosomal storage disorders, and peroxisomal biogenesis disorders can present with similar symptoms to PCH7.
- Genetic Diseases: Other autosomal recessive hereditary neurological degenerative diseases, such as ataxias and spastic paraplegias, may be considered in the differential diagnosis.
Key Features to Consider
When differentiating between these conditions, consider the following key features:
- Clinical Presentation: PCH7 patients typically manifest delayed psychomotor development, hypotonia, breathing abnormalities, and gonadal abnormalities.
- Neuroradiological Characteristics: Imaging studies may show impaired growth of supratentorial structures, leading to microcephaly, severe intellectual delay, and central motor deficits.
Genetic Testing
Genetic testing is crucial in diagnosing PCH7. A compound heterozygous variant of the TOE1 gene has been identified as a cause of this condition [5]. However, other genetic mutations may also be responsible for PCH7.
Consultation with Specialists
A multidisciplinary team, including neurologists, geneticists, and neuroradiologists, should be consulted to aid in the differential diagnosis and management of PCH7 patients.
References:
[4] van Dijk T. (2018). Clinical, neuroradiological, and genetic characteristics of pontocerebellar hypoplasias. [Context 4]
[5] Wei T. (2024). Pontocerebellar dysplasia type 7: a case report. [Context 5]
[6] van Dijk T. (2018). Clinical, neuroradiological, and genetic characteristics of pontocerebellar hypoplasias. [Context 4]
[10] Wei T. (2024). Pontocerebellar dysplasia type 7: a case report. [Context 10]
Additional Differential Diagnoses
- Metabolic Diseases
- Other Pontocerebellar Hypoplasias
- genetic disease
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1302
- owl#annotatedSource
- t341370
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- ORDO:284339
- oboInOwl#creation_date
- 2015-02-04T14:28:28Z
- oboInOwl#created_by
- emitraka
- rdf-schema#comment
- NT MGI.
- oboInOwl#id
- DOID:0060276
- core#notation
- DOID:0060276
- IAO_0000115
- A pontocerebellar hypoplasia that is characterized by delayed psychomotor development, hypotonia, gonadal abnormalities and respiratory failure, has_material_basis_in autosomal recessive mutation in the TOE1 gene.
- rdf-schema#label
- pontocerebellar hypoplasia type 7
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060264
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- relatedICD
- http://example.org/icd10/Q04.3
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.